- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 62/34 - Unsaturated compounds containing ether groups, groups, groups, or groups
Patent holdings for IPC class C07C 62/34
Total number of patents in this class: 30
10-year publication summary
|
3
|
3
|
1
|
3
|
0
|
1
|
0
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4789 |
7 |
| Boehringer Ingelheim International GmbH | 4494 |
3 |
| Les Laboratoires Servier | 501 |
3 |
| Genentech, Inc. | 4090 |
1 |
| Centre National de La Recherche Scientifique | 10914 |
1 |
| Amgen Inc. | 4383 |
1 |
| F. Hoffmann-la Roche Ltd. | 15 |
1 |
| Eli Lilly and Company | 4050 |
1 |
| Florida Atlantic University Board of Trustees | 107 |
1 |
| Fresenius Medical Care Deutschland GmbH | 2218 |
1 |
| Tallinn University of Technology | 86 |
1 |
| Universite Claude Bernard Lyon 1 | 1068 |
1 |
| University of Iowa Research Foundation | 851 |
1 |
| The University of Tokyo | 4333 |
1 |
| Washington University | 1716 |
1 |
| Xenon Pharmaceuticals Inc. | 195 |
1 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1348 |
1 |
| Neoleukin Therapeutics, Inc. | 13 |
1 |
| Merck Sharp & Dohme LLC | 3737 |
1 |
| Senseion Therapeutics, Inc. | 6 |
1 |
| Other owners | 0 |